Vascular Profiler Diagnoses Heart Disease

Designed with advanced technology, the VP-Series system, developed by Omron Healthcare, Inc. (Bannockburn, IL, USA), provides physicians with accurate and easy-to-use non-invasive tools for cardiovascular disease diagnosis and management. Early detection of cardiovascular disease will enable physicians to treat patients earlier and more efficiently, thereby improving patient quality of life. The VP-Series uses patented waveform analysis and vascular evaluation (WAVE) technology to enable accurate results to achieve this goal. The VP-Series includes the VP-1000 and its more enhanced sister version, the VP- 2000.

The system ensures accurate and reliable ABI results by utilizing advanced oscillometric technology that includes simultaneous blood pressure measurements at all four limbs, a dual-chamber cuff system, and a proprietary algorithm. Studies have demonstrated that the VP-1000 produces ABI results that are highly correlated with that from the Doppler method, even in patients with arterial obstructions. The VP-1000 also measures PWV, which is an index of arterial stiffness. Both ABI and PWV are proven indicators for cardiovascular events.

According to the AHA, over 70 million people in the United States alone have one or more forms of cardiovascular disease, with as many as 8-12 million people having PAD. Almost 75% of people with PAD do not have any symptoms.

James Li, general manager of business development at Omron Healthcare stated, "Left untreated, PAD can lead to gangrene and amputation. Early PAD diagnosis is important for effective treatment. The VP-1000 can be readily used in general practice to promote early PAD detection due to its accuracy and ease of use.”




Related Links:
Omron Healthcare